Myricetin ameliorates prediabetes through gut microbiota–SCFAs–Gpr43 axis.

This document is a compilation of scientific articles that discuss the role of gut microbiota in human metabolic health and disease. The articles explore topics such as the impact of gut microbiota on glucose control, energy metabolism, inflammation, and insulin resistance in conditions like type 2 diabetes and prediabetes. They also examine the influence of dietary fiber, short-chain fatty acids, and specific bacteria on gut homeostasis and immune responses. The articles provide insights into the complex interactions between the gut microbiome and host metabolism, suggesting the potential for microbiota-based interventions in the prevention and treatment of metabolic diseases. [Extracted from the article]